Navigation Links
MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
Date:9/20/2012

KENNESAW, Ga., Sept. 20, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane announced today that it will present at the Craig-Hallum 3rd Annual  Alpha Select Conference in New York City.  Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on Thursday, September 27th, at 3:30 p.m. Eastern Time at the Sentry Centers.  A webcast of this presentation will be available on the Company's website, www.mimedx.com

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion® Process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant for homologous use. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 90,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
2. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. MiMedx Group Announces Record Second Quarter Results
5. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
6. MiMedx Group Announces Record First Quarter Results
7. MiMedx Exceeds Revenue Goal for First Quarter of 2012
8. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
9. MiMedx Group Announces 2011 Results
10. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
11. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
(Date:7/18/2017)... ... July 18, 2017 , ... G-CON today announced that it ... for its Patent Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean ... expand the protection of G-CON’s R&D investments and validate the G-CON platform as ...
(Date:7/17/2017)... ... ... Whitehouse Laboratories is excited to announce that it has ... ISO 80369 standard test procedures. The ISO 80369 series of eight test standards ... this recent expansion, Whitehouse Labs becomes one of the only facilities in the ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... a wide range of overlapping clinical features. The advancement of targeted next-generation sequencing ... of NDD research and testing. , However, designing a custom panel for ...
Breaking Biology Technology:
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):